Skip to content
Search

Latest Stories

RPS to boost inclusion and diversity in pharmacy

The Royal Pharmaceutical Society (RPS) is moving ahead with a major plan to boost inclusion and diversity in pharmacy.

Ethnicity pay gap in the pharmacy sector currently stands at 11.7 per cent, while gender pay gap is 14.7 per cent, according to the RPS.


RPS CEO Paul Bennett said: “We want to become a fairer, more inclusive employer and our pay gap work is part of a bigger transformation for both our people and the profession.

"Both pay gaps show there’s still much work to be done and we need to improve. It’s disappointing that efforts to reduce our gender pay gap have yet to make a real difference to our overall results."

Bennett added: "We still have more work to do as we recruit people into more senior roles to ensure they are accessible and welcoming to women and people from BAME backgrounds.

“Change will be incremental, but we are determined to make progress to reduce our ethnicity and gender pay gaps. We will be working with our staff forum, People Team and our internal inclusion and diversity group to build an action plan for our people, which we’ll share with them later this year.

“We’ll also be taking another important step towards inclusion and diversity in pharmacy by publishing our full strategy for the profession on June 22.”

The RPS would use the data as a baseline as it aims to take action to reduce the pay gap.

The pharmacy body also aims to encourage a diverse range of mentors, particularly people who are from BAME backgrounds, including people who are LGBTQ or who have a disability, to help it to understand the challenges in the sector.

“We’ll also be reviewing our recruitment processes to ensure that we’ve done everything we can to be fair and inclusive, to eliminate any potential bias across all our recruitment and particularly to improve representation of BAME employees at senior level within RPS,” it said, adding: “We’ll be working on our more detailed action plans in the course of this year with the involvement and support of our Inclusion and Diversity Group, the Employee Forum and colleagues across RPS.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less